nodes	percent_of_prediction	percent_of_DWPC	metapath
Domperidone—CYP2B6—Thiotepa—urinary bladder cancer	0.176	0.23	CbGbCtD
Domperidone—ABCB1—Mitomycin—urinary bladder cancer	0.119	0.156	CbGbCtD
Domperidone—CYP3A4—Thiotepa—urinary bladder cancer	0.054	0.0706	CbGbCtD
Domperidone—CYP2B6—Cisplatin—urinary bladder cancer	0.0485	0.0634	CbGbCtD
Domperidone—CYP2C8—Fluorouracil—urinary bladder cancer	0.0433	0.0566	CbGbCtD
Domperidone—CYP3A5—Etoposide—urinary bladder cancer	0.0375	0.0491	CbGbCtD
Domperidone—CYP2C8—Etoposide—urinary bladder cancer	0.0361	0.0472	CbGbCtD
Domperidone—ABCB1—Gemcitabine—urinary bladder cancer	0.0342	0.0448	CbGbCtD
Domperidone—CYP1A2—Fluorouracil—urinary bladder cancer	0.0335	0.0438	CbGbCtD
Domperidone—CYP2B6—Doxorubicin—urinary bladder cancer	0.0325	0.0425	CbGbCtD
Domperidone—CYP1A2—Etoposide—urinary bladder cancer	0.0279	0.0365	CbGbCtD
Domperidone—ABCB1—Cisplatin—urinary bladder cancer	0.0249	0.0325	CbGbCtD
Domperidone—ABCB1—Etoposide—urinary bladder cancer	0.0244	0.032	CbGbCtD
Domperidone—ABCB1—Doxorubicin—urinary bladder cancer	0.0167	0.0218	CbGbCtD
Domperidone—ABCB1—Methotrexate—urinary bladder cancer	0.0161	0.0211	CbGbCtD
Domperidone—CYP2D6—Doxorubicin—urinary bladder cancer	0.0157	0.0205	CbGbCtD
Domperidone—CYP3A4—Etoposide—urinary bladder cancer	0.0146	0.0191	CbGbCtD
Domperidone—CYP3A4—Doxorubicin—urinary bladder cancer	0.00999	0.0131	CbGbCtD
Domperidone—Irritability—Valrubicin—urinary bladder cancer	0.0034	0.0323	CcSEcCtD
Domperidone—Dysuria—Valrubicin—urinary bladder cancer	0.00288	0.0273	CcSEcCtD
Domperidone—Pollakiuria—Valrubicin—urinary bladder cancer	0.00285	0.027	CcSEcCtD
Domperidone—Sudden death—Fluorouracil—urinary bladder cancer	0.00275	0.0261	CcSEcCtD
Domperidone—Heartburn—Fluorouracil—urinary bladder cancer	0.00205	0.0194	CcSEcCtD
Domperidone—CYP1A2—urine—urinary bladder cancer	0.00192	0.122	CbGeAlD
Domperidone—Drowsiness—Mitomycin—urinary bladder cancer	0.00189	0.0179	CcSEcCtD
Domperidone—Stomatitis—Mitomycin—urinary bladder cancer	0.00185	0.0175	CcSEcCtD
Domperidone—Sudden death—Methotrexate—urinary bladder cancer	0.00143	0.0136	CcSEcCtD
Domperidone—CYP3A4—urine—urinary bladder cancer	0.00139	0.0883	CbGeAlD
Domperidone—Abdominal pain—Valrubicin—urinary bladder cancer	0.00139	0.0131	CcSEcCtD
Domperidone—CYP2D6—urine—urinary bladder cancer	0.00137	0.0868	CbGeAlD
Domperidone—Asthenia—Valrubicin—urinary bladder cancer	0.00126	0.0119	CcSEcCtD
Domperidone—Pruritus—Valrubicin—urinary bladder cancer	0.00124	0.0118	CcSEcCtD
Domperidone—Oedema—Mitomycin—urinary bladder cancer	0.00121	0.0114	CcSEcCtD
Domperidone—Diarrhoea—Valrubicin—urinary bladder cancer	0.0012	0.0114	CcSEcCtD
Domperidone—Dizziness—Valrubicin—urinary bladder cancer	0.00116	0.011	CcSEcCtD
Domperidone—Disorientation—Fluorouracil—urinary bladder cancer	0.00114	0.0108	CcSEcCtD
Domperidone—Vomiting—Valrubicin—urinary bladder cancer	0.00111	0.0106	CcSEcCtD
Domperidone—Rash—Valrubicin—urinary bladder cancer	0.00111	0.0105	CcSEcCtD
Domperidone—Dermatitis—Valrubicin—urinary bladder cancer	0.0011	0.0105	CcSEcCtD
Domperidone—Headache—Valrubicin—urinary bladder cancer	0.0011	0.0104	CcSEcCtD
Domperidone—Somnolence—Mitomycin—urinary bladder cancer	0.00107	0.0102	CcSEcCtD
Domperidone—Lethargy—Fluorouracil—urinary bladder cancer	0.00104	0.00988	CcSEcCtD
Domperidone—Nausea—Valrubicin—urinary bladder cancer	0.00104	0.00987	CcSEcCtD
Domperidone—Dysuria—Thiotepa—urinary bladder cancer	0.000999	0.00946	CcSEcCtD
Domperidone—Irritability—Fluorouracil—urinary bladder cancer	0.000975	0.00924	CcSEcCtD
Domperidone—Stomatitis—Thiotepa—urinary bladder cancer	0.000928	0.0088	CcSEcCtD
Domperidone—Conjunctivitis—Thiotepa—urinary bladder cancer	0.000926	0.00877	CcSEcCtD
Domperidone—Irritability—Cisplatin—urinary bladder cancer	0.000925	0.00876	CcSEcCtD
Domperidone—Asthenia—Mitomycin—urinary bladder cancer	0.000866	0.00821	CcSEcCtD
Domperidone—Diarrhoea—Mitomycin—urinary bladder cancer	0.000826	0.00783	CcSEcCtD
Domperidone—KCNH2—prostate gland—urinary bladder cancer	0.000807	0.0511	CbGeAlD
Domperidone—Dizziness—Mitomycin—urinary bladder cancer	0.000799	0.00757	CcSEcCtD
Domperidone—Breast pain—Epirubicin—urinary bladder cancer	0.000786	0.00744	CcSEcCtD
Domperidone—Stomatitis—Gemcitabine—urinary bladder cancer	0.000781	0.0074	CcSEcCtD
Domperidone—Vomiting—Mitomycin—urinary bladder cancer	0.000768	0.00728	CcSEcCtD
Domperidone—Stomatitis—Fluorouracil—urinary bladder cancer	0.000768	0.00728	CcSEcCtD
Domperidone—Conjunctivitis—Fluorouracil—urinary bladder cancer	0.000766	0.00725	CcSEcCtD
Domperidone—Arrhythmia—Thiotepa—urinary bladder cancer	0.000764	0.00724	CcSEcCtD
Domperidone—Rash—Mitomycin—urinary bladder cancer	0.000761	0.00722	CcSEcCtD
Domperidone—Dermatitis—Mitomycin—urinary bladder cancer	0.000761	0.00721	CcSEcCtD
Domperidone—Headache—Mitomycin—urinary bladder cancer	0.000757	0.00717	CcSEcCtD
Domperidone—Tension—Thiotepa—urinary bladder cancer	0.00073	0.00692	CcSEcCtD
Domperidone—Stomatitis—Cisplatin—urinary bladder cancer	0.000728	0.0069	CcSEcCtD
Domperidone—Breast pain—Doxorubicin—urinary bladder cancer	0.000727	0.00689	CcSEcCtD
Domperidone—Conjunctivitis—Cisplatin—urinary bladder cancer	0.000726	0.00688	CcSEcCtD
Domperidone—Nervousness—Thiotepa—urinary bladder cancer	0.000723	0.00685	CcSEcCtD
Domperidone—Nausea—Mitomycin—urinary bladder cancer	0.000717	0.0068	CcSEcCtD
Domperidone—KCNH2—seminal vesicle—urinary bladder cancer	0.000682	0.0432	CbGeAlD
Domperidone—Stomatitis—Etoposide—urinary bladder cancer	0.000667	0.00632	CcSEcCtD
Domperidone—CYP3A5—prostate gland—urinary bladder cancer	0.000666	0.0422	CbGeAlD
Domperidone—Gynaecomastia—Methotrexate—urinary bladder cancer	0.000655	0.00621	CcSEcCtD
Domperidone—Arrhythmia—Gemcitabine—urinary bladder cancer	0.000642	0.00609	CcSEcCtD
Domperidone—Arrhythmia—Fluorouracil—urinary bladder cancer	0.000632	0.00599	CcSEcCtD
Domperidone—Cramps of lower extremities—Epirubicin—urinary bladder cancer	0.00063	0.00597	CcSEcCtD
Domperidone—Arrhythmia—Cisplatin—urinary bladder cancer	0.000599	0.00567	CcSEcCtD
Domperidone—Cramps of lower extremities—Doxorubicin—urinary bladder cancer	0.000583	0.00552	CcSEcCtD
Domperidone—Muscle spasms—Cisplatin—urinary bladder cancer	0.000561	0.00532	CcSEcCtD
Domperidone—KCNH2—renal system—urinary bladder cancer	0.00055	0.0348	CbGeAlD
Domperidone—Lethargy—Methotrexate—urinary bladder cancer	0.000543	0.00514	CcSEcCtD
Domperidone—KCNH2—urethra—urinary bladder cancer	0.00054	0.0342	CbGeAlD
Domperidone—Somnolence—Thiotepa—urinary bladder cancer	0.00054	0.00512	CcSEcCtD
Domperidone—Dyspepsia—Thiotepa—urinary bladder cancer	0.000535	0.00507	CcSEcCtD
Domperidone—Hot flush—Epirubicin—urinary bladder cancer	0.000532	0.00504	CcSEcCtD
Domperidone—Menopausal symptoms—Epirubicin—urinary bladder cancer	0.000527	0.005	CcSEcCtD
Domperidone—Constipation—Thiotepa—urinary bladder cancer	0.000519	0.00492	CcSEcCtD
Domperidone—Muscle spasms—Etoposide—urinary bladder cancer	0.000514	0.00487	CcSEcCtD
Domperidone—Oedema—Gemcitabine—urinary bladder cancer	0.000511	0.00484	CcSEcCtD
Domperidone—Lethargy—Epirubicin—urinary bladder cancer	0.000508	0.00481	CcSEcCtD
Domperidone—Irritability—Methotrexate—urinary bladder cancer	0.000507	0.00481	CcSEcCtD
Domperidone—CYP2C8—renal system—urinary bladder cancer	0.000503	0.0319	CbGeAlD
Domperidone—Oedema—Fluorouracil—urinary bladder cancer	0.000502	0.00476	CcSEcCtD
Domperidone—Hot flush—Doxorubicin—urinary bladder cancer	0.000492	0.00466	CcSEcCtD
Domperidone—Migraine—Epirubicin—urinary bladder cancer	0.00049	0.00464	CcSEcCtD
Domperidone—Menopausal symptoms—Doxorubicin—urinary bladder cancer	0.000488	0.00462	CcSEcCtD
Domperidone—Urticaria—Thiotepa—urinary bladder cancer	0.000482	0.00457	CcSEcCtD
Domperidone—Abdominal pain—Thiotepa—urinary bladder cancer	0.00048	0.00455	CcSEcCtD
Domperidone—Hypotension—Gemcitabine—urinary bladder cancer	0.000477	0.00452	CcSEcCtD
Domperidone—Oedema—Cisplatin—urinary bladder cancer	0.000476	0.00451	CcSEcCtD
Domperidone—CYP1A2—renal system—urinary bladder cancer	0.000471	0.0298	CbGeAlD
Domperidone—Lethargy—Doxorubicin—urinary bladder cancer	0.00047	0.00445	CcSEcCtD
Domperidone—Hypotension—Fluorouracil—urinary bladder cancer	0.000469	0.00445	CcSEcCtD
Domperidone—Insomnia—Gemcitabine—urinary bladder cancer	0.000462	0.00438	CcSEcCtD
Domperidone—Insomnia—Fluorouracil—urinary bladder cancer	0.000454	0.00431	CcSEcCtD
Domperidone—Somnolence—Gemcitabine—urinary bladder cancer	0.000454	0.0043	CcSEcCtD
Domperidone—CYP3A5—renal system—urinary bladder cancer	0.000454	0.0288	CbGeAlD
Domperidone—Migraine—Doxorubicin—urinary bladder cancer	0.000453	0.00429	CcSEcCtD
Domperidone—CYP2B6—renal system—urinary bladder cancer	0.000451	0.0286	CbGeAlD
Domperidone—Somnolence—Fluorouracil—urinary bladder cancer	0.000447	0.00423	CcSEcCtD
Domperidone—Hypotension—Cisplatin—urinary bladder cancer	0.000445	0.00422	CcSEcCtD
Domperidone—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000442	0.00419	CcSEcCtD
Domperidone—KCNH2—female reproductive system—urinary bladder cancer	0.00044	0.0279	CbGeAlD
Domperidone—Constipation—Gemcitabine—urinary bladder cancer	0.000437	0.00414	CcSEcCtD
Domperidone—Asthenia—Thiotepa—urinary bladder cancer	0.000436	0.00413	CcSEcCtD
Domperidone—Dysuria—Methotrexate—urinary bladder cancer	0.00043	0.00407	CcSEcCtD
Domperidone—Pruritus—Thiotepa—urinary bladder cancer	0.00043	0.00407	CcSEcCtD
Domperidone—Diarrhoea—Thiotepa—urinary bladder cancer	0.000416	0.00394	CcSEcCtD
Domperidone—Drowsiness—Methotrexate—urinary bladder cancer	0.00041	0.00388	CcSEcCtD
Domperidone—Hypotension—Etoposide—urinary bladder cancer	0.000408	0.00386	CcSEcCtD
Domperidone—CYP2C8—female reproductive system—urinary bladder cancer	0.000403	0.0255	CbGeAlD
Domperidone—Dysuria—Epirubicin—urinary bladder cancer	0.000402	0.00381	CcSEcCtD
Domperidone—Dizziness—Thiotepa—urinary bladder cancer	0.000402	0.00381	CcSEcCtD
Domperidone—Stomatitis—Methotrexate—urinary bladder cancer	0.000399	0.00378	CcSEcCtD
Domperidone—Urticaria—Fluorouracil—urinary bladder cancer	0.000399	0.00378	CcSEcCtD
Domperidone—Conjunctivitis—Methotrexate—urinary bladder cancer	0.000398	0.00377	CcSEcCtD
Domperidone—KCNH2—vagina—urinary bladder cancer	0.000398	0.0252	CbGeAlD
Domperidone—Pollakiuria—Epirubicin—urinary bladder cancer	0.000397	0.00376	CcSEcCtD
Domperidone—Somnolence—Etoposide—urinary bladder cancer	0.000388	0.00368	CcSEcCtD
Domperidone—Vomiting—Thiotepa—urinary bladder cancer	0.000386	0.00366	CcSEcCtD
Domperidone—Drowsiness—Epirubicin—urinary bladder cancer	0.000383	0.00363	CcSEcCtD
Domperidone—Rash—Thiotepa—urinary bladder cancer	0.000383	0.00363	CcSEcCtD
Domperidone—Dermatitis—Thiotepa—urinary bladder cancer	0.000383	0.00363	CcSEcCtD
Domperidone—Headache—Thiotepa—urinary bladder cancer	0.00038	0.00361	CcSEcCtD
Domperidone—Stomatitis—Epirubicin—urinary bladder cancer	0.000374	0.00354	CcSEcCtD
Domperidone—Constipation—Etoposide—urinary bladder cancer	0.000373	0.00354	CcSEcCtD
Domperidone—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000373	0.00353	CcSEcCtD
Domperidone—Dysuria—Doxorubicin—urinary bladder cancer	0.000372	0.00353	CcSEcCtD
Domperidone—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000368	0.00348	CcSEcCtD
Domperidone—Asthenia—Gemcitabine—urinary bladder cancer	0.000367	0.00347	CcSEcCtD
Domperidone—CYP2C8—vagina—urinary bladder cancer	0.000364	0.0231	CbGeAlD
Domperidone—Pruritus—Gemcitabine—urinary bladder cancer	0.000361	0.00343	CcSEcCtD
Domperidone—CYP2B6—female reproductive system—urinary bladder cancer	0.000361	0.0229	CbGeAlD
Domperidone—Nausea—Thiotepa—urinary bladder cancer	0.000361	0.00342	CcSEcCtD
Domperidone—Pruritus—Fluorouracil—urinary bladder cancer	0.000355	0.00337	CcSEcCtD
Domperidone—Drowsiness—Doxorubicin—urinary bladder cancer	0.000355	0.00336	CcSEcCtD
Domperidone—ABCB1—prostate gland—urinary bladder cancer	0.000354	0.0224	CbGeAlD
Domperidone—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00035	0.00331	CcSEcCtD
Domperidone—Urticaria—Etoposide—urinary bladder cancer	0.000347	0.00328	CcSEcCtD
Domperidone—Stomatitis—Doxorubicin—urinary bladder cancer	0.000346	0.00328	CcSEcCtD
Domperidone—Abdominal pain—Etoposide—urinary bladder cancer	0.000345	0.00327	CcSEcCtD
Domperidone—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000345	0.00327	CcSEcCtD
Domperidone—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000344	0.00326	CcSEcCtD
Domperidone—Asthenia—Cisplatin—urinary bladder cancer	0.000342	0.00324	CcSEcCtD
Domperidone—CYP3A4—renal system—urinary bladder cancer	0.000341	0.0216	CbGeAlD
Domperidone—CYP2D6—renal system—urinary bladder cancer	0.000335	0.0212	CbGeAlD
Domperidone—Dizziness—Fluorouracil—urinary bladder cancer	0.000332	0.00315	CcSEcCtD
Domperidone—CYP3A5—vagina—urinary bladder cancer	0.000329	0.0208	CbGeAlD
Domperidone—CYP2B6—vagina—urinary bladder cancer	0.000327	0.0207	CbGeAlD
Domperidone—Diarrhoea—Cisplatin—urinary bladder cancer	0.000326	0.00309	CcSEcCtD
Domperidone—Vomiting—Gemcitabine—urinary bladder cancer	0.000325	0.00308	CcSEcCtD
Domperidone—Rash—Gemcitabine—urinary bladder cancer	0.000322	0.00305	CcSEcCtD
Domperidone—Dermatitis—Gemcitabine—urinary bladder cancer	0.000322	0.00305	CcSEcCtD
Domperidone—Headache—Gemcitabine—urinary bladder cancer	0.00032	0.00303	CcSEcCtD
Domperidone—Vomiting—Fluorouracil—urinary bladder cancer	0.000319	0.00303	CcSEcCtD
Domperidone—Rash—Fluorouracil—urinary bladder cancer	0.000317	0.003	CcSEcCtD
Domperidone—Dermatitis—Fluorouracil—urinary bladder cancer	0.000316	0.003	CcSEcCtD
Domperidone—Headache—Fluorouracil—urinary bladder cancer	0.000315	0.00298	CcSEcCtD
Domperidone—Asthenia—Etoposide—urinary bladder cancer	0.000313	0.00297	CcSEcCtD
Domperidone—Pruritus—Etoposide—urinary bladder cancer	0.000309	0.00292	CcSEcCtD
Domperidone—Arrhythmia—Epirubicin—urinary bladder cancer	0.000307	0.00291	CcSEcCtD
Domperidone—Nausea—Gemcitabine—urinary bladder cancer	0.000303	0.00288	CcSEcCtD
Domperidone—Vomiting—Cisplatin—urinary bladder cancer	0.000303	0.00287	CcSEcCtD
Domperidone—Rash—Cisplatin—urinary bladder cancer	0.0003	0.00285	CcSEcCtD
Domperidone—Dermatitis—Cisplatin—urinary bladder cancer	0.0003	0.00284	CcSEcCtD
Domperidone—ABCB1—seminal vesicle—urinary bladder cancer	0.000299	0.019	CbGeAlD
Domperidone—Diarrhoea—Etoposide—urinary bladder cancer	0.000298	0.00283	CcSEcCtD
Domperidone—Nausea—Fluorouracil—urinary bladder cancer	0.000298	0.00283	CcSEcCtD
Domperidone—Tension—Epirubicin—urinary bladder cancer	0.000294	0.00279	CcSEcCtD
Domperidone—Nervousness—Epirubicin—urinary bladder cancer	0.000291	0.00276	CcSEcCtD
Domperidone—Dizziness—Etoposide—urinary bladder cancer	0.000288	0.00273	CcSEcCtD
Domperidone—Muscle spasms—Epirubicin—urinary bladder cancer	0.000288	0.00273	CcSEcCtD
Domperidone—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000285	0.0027	CcSEcCtD
Domperidone—Nausea—Cisplatin—urinary bladder cancer	0.000283	0.00268	CcSEcCtD
Domperidone—Vomiting—Etoposide—urinary bladder cancer	0.000277	0.00263	CcSEcCtD
Domperidone—Rash—Etoposide—urinary bladder cancer	0.000275	0.00261	CcSEcCtD
Domperidone—Dermatitis—Etoposide—urinary bladder cancer	0.000275	0.0026	CcSEcCtD
Domperidone—Headache—Etoposide—urinary bladder cancer	0.000273	0.00259	CcSEcCtD
Domperidone—CYP3A4—female reproductive system—urinary bladder cancer	0.000273	0.0173	CbGeAlD
Domperidone—Tension—Doxorubicin—urinary bladder cancer	0.000272	0.00258	CcSEcCtD
Domperidone—Nervousness—Doxorubicin—urinary bladder cancer	0.000269	0.00255	CcSEcCtD
Domperidone—CYP2D6—female reproductive system—urinary bladder cancer	0.000269	0.017	CbGeAlD
Domperidone—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000267	0.00253	CcSEcCtD
Domperidone—Palpitations—Epirubicin—urinary bladder cancer	0.000265	0.00251	CcSEcCtD
Domperidone—ABCB1—epithelium—urinary bladder cancer	0.00026	0.0165	CbGeAlD
Domperidone—Nausea—Etoposide—urinary bladder cancer	0.000259	0.00246	CcSEcCtD
Domperidone—KCNH2—lymph node—urinary bladder cancer	0.000258	0.0163	CbGeAlD
Domperidone—Dry mouth—Epirubicin—urinary bladder cancer	0.000249	0.00236	CcSEcCtD
Domperidone—Palpitations—Doxorubicin—urinary bladder cancer	0.000245	0.00232	CcSEcCtD
Domperidone—Oedema—Epirubicin—urinary bladder cancer	0.000245	0.00232	CcSEcCtD
Domperidone—Hypotension—Methotrexate—urinary bladder cancer	0.000244	0.00231	CcSEcCtD
Domperidone—ABCB1—renal system—urinary bladder cancer	0.000241	0.0153	CbGeAlD
Domperidone—ABCB1—urethra—urinary bladder cancer	0.000237	0.015	CbGeAlD
Domperidone—Insomnia—Methotrexate—urinary bladder cancer	0.000236	0.00224	CcSEcCtD
Domperidone—Somnolence—Methotrexate—urinary bladder cancer	0.000232	0.0022	CcSEcCtD
Domperidone—Dry mouth—Doxorubicin—urinary bladder cancer	0.000231	0.00219	CcSEcCtD
Domperidone—Dyspepsia—Methotrexate—urinary bladder cancer	0.00023	0.00218	CcSEcCtD
Domperidone—Hypotension—Epirubicin—urinary bladder cancer	0.000229	0.00217	CcSEcCtD
Domperidone—Oedema—Doxorubicin—urinary bladder cancer	0.000226	0.00214	CcSEcCtD
Domperidone—Insomnia—Epirubicin—urinary bladder cancer	0.000221	0.0021	CcSEcCtD
Domperidone—Somnolence—Epirubicin—urinary bladder cancer	0.000217	0.00206	CcSEcCtD
Domperidone—Dyspepsia—Epirubicin—urinary bladder cancer	0.000215	0.00204	CcSEcCtD
Domperidone—Hypotension—Doxorubicin—urinary bladder cancer	0.000211	0.002	CcSEcCtD
Domperidone—Constipation—Epirubicin—urinary bladder cancer	0.000209	0.00198	CcSEcCtD
Domperidone—Urticaria—Methotrexate—urinary bladder cancer	0.000208	0.00197	CcSEcCtD
Domperidone—Abdominal pain—Methotrexate—urinary bladder cancer	0.000207	0.00196	CcSEcCtD
Domperidone—Insomnia—Doxorubicin—urinary bladder cancer	0.000205	0.00194	CcSEcCtD
Domperidone—Somnolence—Doxorubicin—urinary bladder cancer	0.000201	0.00191	CcSEcCtD
Domperidone—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000199	0.00189	CcSEcCtD
Domperidone—Urticaria—Epirubicin—urinary bladder cancer	0.000194	0.00184	CcSEcCtD
Domperidone—Constipation—Doxorubicin—urinary bladder cancer	0.000193	0.00183	CcSEcCtD
Domperidone—Abdominal pain—Epirubicin—urinary bladder cancer	0.000193	0.00183	CcSEcCtD
Domperidone—ABCB1—female reproductive system—urinary bladder cancer	0.000193	0.0122	CbGeAlD
Domperidone—Asthenia—Methotrexate—urinary bladder cancer	0.000187	0.00178	CcSEcCtD
Domperidone—Pruritus—Methotrexate—urinary bladder cancer	0.000185	0.00175	CcSEcCtD
Domperidone—Urticaria—Doxorubicin—urinary bladder cancer	0.00018	0.0017	CcSEcCtD
Domperidone—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000179	0.0017	CcSEcCtD
Domperidone—Diarrhoea—Methotrexate—urinary bladder cancer	0.000179	0.00169	CcSEcCtD
Domperidone—Asthenia—Epirubicin—urinary bladder cancer	0.000175	0.00166	CcSEcCtD
Domperidone—ABCB1—vagina—urinary bladder cancer	0.000175	0.0111	CbGeAlD
Domperidone—Pruritus—Epirubicin—urinary bladder cancer	0.000173	0.00164	CcSEcCtD
Domperidone—Dizziness—Methotrexate—urinary bladder cancer	0.000173	0.00164	CcSEcCtD
Domperidone—Diarrhoea—Epirubicin—urinary bladder cancer	0.000167	0.00159	CcSEcCtD
Domperidone—Vomiting—Methotrexate—urinary bladder cancer	0.000166	0.00157	CcSEcCtD
Domperidone—Rash—Methotrexate—urinary bladder cancer	0.000165	0.00156	CcSEcCtD
Domperidone—Dermatitis—Methotrexate—urinary bladder cancer	0.000165	0.00156	CcSEcCtD
Domperidone—Headache—Methotrexate—urinary bladder cancer	0.000164	0.00155	CcSEcCtD
Domperidone—Asthenia—Doxorubicin—urinary bladder cancer	0.000162	0.00154	CcSEcCtD
Domperidone—Dizziness—Epirubicin—urinary bladder cancer	0.000162	0.00153	CcSEcCtD
Domperidone—Pruritus—Doxorubicin—urinary bladder cancer	0.00016	0.00152	CcSEcCtD
Domperidone—Vomiting—Epirubicin—urinary bladder cancer	0.000155	0.00147	CcSEcCtD
Domperidone—Nausea—Methotrexate—urinary bladder cancer	0.000155	0.00147	CcSEcCtD
Domperidone—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000155	0.00147	CcSEcCtD
Domperidone—Rash—Epirubicin—urinary bladder cancer	0.000154	0.00146	CcSEcCtD
Domperidone—Dermatitis—Epirubicin—urinary bladder cancer	0.000154	0.00146	CcSEcCtD
Domperidone—Headache—Epirubicin—urinary bladder cancer	0.000153	0.00145	CcSEcCtD
Domperidone—Dizziness—Doxorubicin—urinary bladder cancer	0.00015	0.00142	CcSEcCtD
Domperidone—Nausea—Epirubicin—urinary bladder cancer	0.000145	0.00138	CcSEcCtD
Domperidone—Vomiting—Doxorubicin—urinary bladder cancer	0.000144	0.00136	CcSEcCtD
Domperidone—Rash—Doxorubicin—urinary bladder cancer	0.000143	0.00135	CcSEcCtD
Domperidone—Dermatitis—Doxorubicin—urinary bladder cancer	0.000143	0.00135	CcSEcCtD
Domperidone—Headache—Doxorubicin—urinary bladder cancer	0.000142	0.00134	CcSEcCtD
Domperidone—Nausea—Doxorubicin—urinary bladder cancer	0.000134	0.00127	CcSEcCtD
Domperidone—ABCB1—lymph node—urinary bladder cancer	0.000113	0.00716	CbGeAlD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	3.94e-05	0.000346	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—RBX1—urinary bladder cancer	3.9e-05	0.000342	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	3.9e-05	0.000342	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	3.88e-05	0.000341	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—NAT2—urinary bladder cancer	3.86e-05	0.000339	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	3.81e-05	0.000335	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	3.81e-05	0.000334	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	3.8e-05	0.000333	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.71e-05	0.000326	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—TYMP—urinary bladder cancer	3.7e-05	0.000325	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—TSC1—urinary bladder cancer	3.67e-05	0.000322	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	3.63e-05	0.000319	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.55e-05	0.000312	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	3.53e-05	0.00031	CbGpPWpGaD
Domperidone—DRD2—GPCR ligand binding—CXCL8—urinary bladder cancer	3.51e-05	0.000308	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	3.5e-05	0.000307	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—JAG1—urinary bladder cancer	3.49e-05	0.000306	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	3.46e-05	0.000303	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—NQO1—urinary bladder cancer	3.44e-05	0.000302	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—RRM2—urinary bladder cancer	3.41e-05	0.000299	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—NAT2—urinary bladder cancer	3.35e-05	0.000294	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—RRM2—urinary bladder cancer	3.33e-05	0.000293	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	3.3e-05	0.00029	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	3.28e-05	0.000288	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—NAT1—urinary bladder cancer	3.28e-05	0.000288	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—TYMP—urinary bladder cancer	3.22e-05	0.000283	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	3.22e-05	0.000282	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	3.16e-05	0.000278	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—ENO2—urinary bladder cancer	3.16e-05	0.000277	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	3.16e-05	0.000277	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	3.09e-05	0.000272	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—ENO2—urinary bladder cancer	3.09e-05	0.000271	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	3.09e-05	0.000271	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	3.06e-05	0.000269	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—TYMP—urinary bladder cancer	3.04e-05	0.000267	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	3e-05	0.000263	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	3e-05	0.000263	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—RBX1—urinary bladder cancer	2.98e-05	0.000262	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—RHOA—urinary bladder cancer	2.95e-05	0.000259	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.95e-05	0.000259	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.92e-05	0.000256	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—NAT2—urinary bladder cancer	2.91e-05	0.000256	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—RRM2—urinary bladder cancer	2.89e-05	0.000253	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	2.87e-05	0.000252	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—S100B—urinary bladder cancer	2.83e-05	0.000248	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TSC1—urinary bladder cancer	2.81e-05	0.000246	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—NAT2—urinary bladder cancer	2.75e-05	0.000241	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.7e-05	0.000237	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—RHOA—urinary bladder cancer	2.68e-05	0.000235	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	2.67e-05	0.000235	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—ENO2—urinary bladder cancer	2.67e-05	0.000235	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—JAG1—urinary bladder cancer	2.67e-05	0.000234	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—TYMS—urinary bladder cancer	2.67e-05	0.000234	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.66e-05	0.000233	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	2.64e-05	0.000232	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	2.64e-05	0.000232	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.6e-05	0.000228	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	2.59e-05	0.000228	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—CXCL8—urinary bladder cancer	2.59e-05	0.000227	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.58e-05	0.000226	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—TYMP—urinary bladder cancer	2.57e-05	0.000226	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.55e-05	0.000224	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.55e-05	0.000224	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—NQO1—urinary bladder cancer	2.55e-05	0.000223	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—NCOR1—urinary bladder cancer	2.54e-05	0.000223	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—GPX1—urinary bladder cancer	2.53e-05	0.000222	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—RRM2—urinary bladder cancer	2.52e-05	0.000221	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—NQO1—urinary bladder cancer	2.49e-05	0.000218	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.48e-05	0.000218	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	2.48e-05	0.000218	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—IL2—urinary bladder cancer	2.48e-05	0.000217	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.47e-05	0.000217	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—RRM2—urinary bladder cancer	2.37e-05	0.000208	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—CXCL8—urinary bladder cancer	2.35e-05	0.000206	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	2.33e-05	0.000205	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—HPGDS—urinary bladder cancer	2.33e-05	0.000205	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—ENO2—urinary bladder cancer	2.33e-05	0.000205	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—NAT2—urinary bladder cancer	2.33e-05	0.000204	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GSTT1—urinary bladder cancer	2.26e-05	0.000198	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—RHOA—urinary bladder cancer	2.26e-05	0.000198	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—IL2—urinary bladder cancer	2.25e-05	0.000197	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—TERT—urinary bladder cancer	2.24e-05	0.000197	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	2.2e-05	0.000193	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—ENO2—urinary bladder cancer	2.2e-05	0.000193	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—S100B—urinary bladder cancer	2.16e-05	0.00019	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—NQO1—urinary bladder cancer	2.16e-05	0.000189	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	2.13e-05	0.000187	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	2.12e-05	0.000186	CbGpPWpGaD
Domperidone—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.12e-05	0.000186	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.09e-05	0.000184	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	2.08e-05	0.000182	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—FGFR3—urinary bladder cancer	2.06e-05	0.00018	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—RHOA—urinary bladder cancer	2.05e-05	0.00018	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—RRM2—urinary bladder cancer	2.01e-05	0.000176	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—ESR1—urinary bladder cancer	2e-05	0.000175	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.99e-05	0.000174	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.98e-05	0.000174	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—TYMS—urinary bladder cancer	1.97e-05	0.000173	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	1.95e-05	0.000171	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	1.95e-05	0.000171	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—NCOR1—urinary bladder cancer	1.94e-05	0.000171	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—TYMS—urinary bladder cancer	1.93e-05	0.000169	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	1.91e-05	0.000167	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	1.91e-05	0.000167	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—IL2—urinary bladder cancer	1.89e-05	0.000166	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PPARG—urinary bladder cancer	1.89e-05	0.000166	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.88e-05	0.000165	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—GPX1—urinary bladder cancer	1.87e-05	0.000164	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ENO2—urinary bladder cancer	1.86e-05	0.000163	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	1.86e-05	0.000163	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.85e-05	0.000162	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	1.84e-05	0.000161	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—GPX1—urinary bladder cancer	1.83e-05	0.00016	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.82e-05	0.00016	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	1.82e-05	0.000159	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	1.8e-05	0.000158	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—CXCL8—urinary bladder cancer	1.8e-05	0.000158	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	1.8e-05	0.000158	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.8e-05	0.000158	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	1.79e-05	0.000157	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.78e-05	0.000156	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—NQO1—urinary bladder cancer	1.77e-05	0.000155	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CREBBP—urinary bladder cancer	1.75e-05	0.000154	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.74e-05	0.000153	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IGF1—urinary bladder cancer	1.73e-05	0.000152	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	1.72e-05	0.000151	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—IL2—urinary bladder cancer	1.72e-05	0.000151	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—EGFR—urinary bladder cancer	1.72e-05	0.000151	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TERT—urinary bladder cancer	1.71e-05	0.00015	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	1.69e-05	0.000148	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—TYMS—urinary bladder cancer	1.67e-05	0.000147	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	1.65e-05	0.000145	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	1.65e-05	0.000145	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—KRAS—urinary bladder cancer	1.62e-05	0.000143	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—RHOA—urinary bladder cancer	1.58e-05	0.000139	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—GPX1—urinary bladder cancer	1.58e-05	0.000139	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—FGFR3—urinary bladder cancer	1.57e-05	0.000138	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.57e-05	0.000137	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	1.55e-05	0.000136	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.55e-05	0.000136	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—ESR1—urinary bladder cancer	1.53e-05	0.000134	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—NQO1—urinary bladder cancer	1.5e-05	0.000132	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	1.49e-05	0.000131	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	1.48e-05	0.00013	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—ERBB2—urinary bladder cancer	1.47e-05	0.000129	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	1.46e-05	0.000128	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.46e-05	0.000128	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.45e-05	0.000128	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.44e-05	0.000126	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.44e-05	0.000126	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.44e-05	0.000126	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.44e-05	0.000126	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PPARG—urinary bladder cancer	1.4e-05	0.000123	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.39e-05	0.000122	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CXCL8—urinary bladder cancer	1.39e-05	0.000122	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—HRAS—urinary bladder cancer	1.38e-05	0.000121	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.38e-05	0.000121	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—TYMS—urinary bladder cancer	1.37e-05	0.00012	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PPARG—urinary bladder cancer	1.37e-05	0.00012	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	1.36e-05	0.000119	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	1.36e-05	0.000119	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.35e-05	0.000119	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	1.34e-05	0.000118	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CREBBP—urinary bladder cancer	1.34e-05	0.000117	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IL2—urinary bladder cancer	1.33e-05	0.000117	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IGF1—urinary bladder cancer	1.32e-05	0.000116	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—EGFR—urinary bladder cancer	1.32e-05	0.000115	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	1.31e-05	0.000115	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GPX1—urinary bladder cancer	1.3e-05	0.000114	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PTEN—urinary bladder cancer	1.3e-05	0.000114	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CCND1—urinary bladder cancer	1.29e-05	0.000114	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.28e-05	0.000112	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.27e-05	0.000112	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.27e-05	0.000111	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MMP9—urinary bladder cancer	1.26e-05	0.00011	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CDKN1A—urinary bladder cancer	1.25e-05	0.00011	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.25e-05	0.00011	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PTEN—urinary bladder cancer	1.25e-05	0.00011	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—KRAS—urinary bladder cancer	1.24e-05	0.000109	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—EP300—urinary bladder cancer	1.24e-05	0.000109	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—RHOA—urinary bladder cancer	1.21e-05	0.000106	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.21e-05	0.000106	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.2e-05	0.000105	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—EP300—urinary bladder cancer	1.19e-05	0.000105	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PPARG—urinary bladder cancer	1.18e-05	0.000104	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.16e-05	0.000102	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—SRC—urinary bladder cancer	1.16e-05	0.000102	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.16e-05	0.000102	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.15e-05	0.000101	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.15e-05	0.000101	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	1.14e-05	9.98e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—ERBB2—urinary bladder cancer	1.12e-05	9.84e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.1e-05	9.66e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	1.1e-05	9.66e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.08e-05	9.48e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	1.08e-05	9.44e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CXCL8—urinary bladder cancer	1.06e-05	9.33e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—HRAS—urinary bladder cancer	1.06e-05	9.27e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MYC—urinary bladder cancer	1.04e-05	9.11e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.03e-05	9.05e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IL2—urinary bladder cancer	1.02e-05	8.92e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.02e-05	8.91e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—EGFR—urinary bladder cancer	1.02e-05	8.91e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CREBBP—urinary bladder cancer	9.91e-06	8.7e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CCND1—urinary bladder cancer	9.91e-06	8.69e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PPARG—urinary bladder cancer	9.72e-06	8.53e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	9.65e-06	8.47e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MMP9—urinary bladder cancer	9.62e-06	8.44e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PTEN—urinary bladder cancer	9.6e-06	8.42e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—KRAS—urinary bladder cancer	9.59e-06	8.42e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CDKN1A—urinary bladder cancer	9.58e-06	8.41e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PTEN—urinary bladder cancer	9.56e-06	8.39e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PTEN—urinary bladder cancer	9.38e-06	8.23e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	9.34e-06	8.2e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	9.32e-06	8.18e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—EP300—urinary bladder cancer	9.15e-06	8.03e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—EP300—urinary bladder cancer	9.12e-06	8e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—TYMS—urinary bladder cancer	8.97e-06	7.87e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—EP300—urinary bladder cancer	8.94e-06	7.85e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	8.87e-06	7.78e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	8.87e-06	7.78e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—SRC—urinary bladder cancer	8.87e-06	7.78e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—TP53—urinary bladder cancer	8.53e-06	7.48e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GPX1—urinary bladder cancer	8.49e-06	7.45e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	8.34e-06	7.32e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PPARG—urinary bladder cancer	8.24e-06	7.23e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—HRAS—urinary bladder cancer	8.15e-06	7.16e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PTEN—urinary bladder cancer	8.12e-06	7.13e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PTGS2—urinary bladder cancer	8.12e-06	7.12e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MYC—urinary bladder cancer	7.95e-06	6.97e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	7.91e-06	6.94e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	7.84e-06	6.88e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—EGFR—urinary bladder cancer	7.77e-06	6.82e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—EP300—urinary bladder cancer	7.75e-06	6.8e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	7.65e-06	6.71e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—KRAS—urinary bladder cancer	7.34e-06	6.44e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PTEN—urinary bladder cancer	7.08e-06	6.21e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—EP300—urinary bladder cancer	6.75e-06	5.92e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PTEN—urinary bladder cancer	6.67e-06	5.85e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TP53—urinary bladder cancer	6.52e-06	5.73e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	6.48e-06	5.69e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—EP300—urinary bladder cancer	6.36e-06	5.58e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PPARG—urinary bladder cancer	6.36e-06	5.58e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—HRAS—urinary bladder cancer	6.24e-06	5.48e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	6.11e-06	5.36e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PTEN—urinary bladder cancer	5.65e-06	4.96e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—EP300—urinary bladder cancer	5.39e-06	4.73e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	5e-06	4.39e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.36e-06	3.83e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—EP300—urinary bladder cancer	4.16e-06	3.65e-05	CbGpPWpGaD
